RenovoRx Inc (NASDAQ: RNXT) open the trading on Wednesday, with a bit cautious approach as it glided -7.08% to $1.05, before settling in for the price of $1.13 at the close. Taking a more long-term approach, RNXT posted a 52-week range of $0.75-$1.69.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 2.24%. Meanwhile, its Annual Earning per share during the time was 2.24%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 20.63%. This publicly-traded company’s shares outstanding now amounts to $36.65 million, simultaneously with a float of $35.38 million. The organization now has a market capitalization sitting at $38.48 million. At the time of writing, stock’s 50-day Moving Average stood at $1.1568, while the 200-day Moving Average is $1.1594.
RenovoRx Inc (RNXT) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. RenovoRx Inc’s current insider ownership accounts for 3.44%, in contrast to 24.00% institutional ownership. According to the most recent insider trade that took place on Aug 22 ’25, this organization’s Chief Executive Officer bought 5,000 shares at the rate of 0.95, making the entire transaction reach 4,748 in total value, affecting insider ownership by 325,040. Preceding that transaction, on Aug 25 ’25, Company’s Chief Executive Officer bought 5,000 for 0.91, making the whole transaction’s value amount to 4,549. This particular insider is now the holder of 330,040 in total.
RenovoRx Inc (RNXT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
RenovoRx Inc’s EPS increase for this current 12-month fiscal period is 20.63% and is forecasted to reach -0.34 in the upcoming year.
RenovoRx Inc (NASDAQ: RNXT) Trading Performance Indicators
Let’s observe the current performance indicators for RenovoRx Inc (RNXT). It’s Quick Ratio in the last reported quarter now stands at 8.61. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 58.30.
In the same vein, RNXT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.38, a figure that is expected to reach -0.08 in the next quarter, and analysts are predicting that it will be -0.34 at the market close of one year from today.
Technical Analysis of RenovoRx Inc (RNXT)
[RenovoRx Inc, RNXT] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 20.18% While, its Average True Range was 36.73.
Raw Stochastic average of RenovoRx Inc (RNXT) in the period of the previous 100 days is set at 38.46%, which indicates a major rise in contrast to 16.67% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0860 that was higher than 0.0848 volatility it exhibited in the past 100-days period.
